Journal of Oral Pathology and Medicine · 2009 · 56 citations · 21 references
MedicineOral PathologyPathologyCarcinogenesisCellular PathologyTumor MicroenvironmentEpithelial TumorsEpithelial-mesenchymal InteractionsEpithelial-mesenchymal TransitionEpithelial-to-mesenchymal TransitionImmunohistochemistryMesenchymal TumorsEpithelial-mesenchymal TransformationEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersImmunohistochemical MarkersImmunohistochemical StainingMesenchymal TransitionParaffin-embedded Tissue StainingPodoplanin Expression
OBJECTIVE: Podoplanin, a mucin-type transmembrane glycoprotein, is specifically expressed by lymphatic but not blood vascular endothelial cells, and is also widely expressed in various specialized cell types throughout the body. Recent studies have demonstrated that it mediates a pathway leading to collective cell migration and invasion in vivo and in vitro. In the present study, we carried out an immunohistochemical investigation of podoplanin to clarify whether it is expressed in human ameloblastomas (AMs), which are characterized by locally aggressive behavior with a high rate of recurrence. In addition, we examined the localization of the epithelial marker E-cadherin and the mesenchymal marker vimentin to clarify whether AMs show epithelial-mesenchymal transition (EMT). METHODS: Paraffin-embedded tissue specimens of 38 AMs were examined immunohistochemically using antibodies against podoplanin, E-cadherin, and vimentin. RESULTS: Immunohistochemical reactivity for podoplanin was detected in the cell membrane and cytoplasm of most odontogenic tumor epithelial cells in AMs. Podoplanin was expressed strongly in peripheral columnar cells and slightly in central stellate reticulum-like cells. E-cadherin was expressed in central stellate reticulum-like cells and showed decreased expression in peripheral columnar cells. Immunoreactivity for E-cadherin was weak or negative in keratinizing cells of acanthomatous AMs, suggesting terminal differentiation of the tumor cells. Immunohistochemical reactivity for vimentin was found in stromal cells, but partial or no reaction was observed in neoplastic cells. CONCLUSION: Expression of podoplanin in AMs is considered to be associated with neoplastic odontogenic tissues; this molecule might play a role in the collective cell migration of tumor nests in AMs. The pattern of expression of E-cadherin and vimentin suggests that invasion in AMs occurs in the absence of EMT. The migration and invasion mediated by podoplanin in AMs could be related to cytoskeletal reorganization.
21
Vivien Schacht, Soheil S. Dadras, Louise A. Johnson et al. · American Journal Of Pathology · 2005 · 596 citations · Full text
Overexpression of podoplanin in oral cancer and its association with poor clinical outcome
Ping Yuan, Stéphane Temam, Adel K. El‐Naggar et al. · Cancer · 2006 · 305 citations · Full text
Medicine, Oncology, Oral Pathology +17